Skip to Content for Media Menu for Media About Us Menu Research Menu Development Menu Medicines Menu Investors Menu Media Menu Careers Menu
Banner Image

Media

Newsroom

The Media section provides reporters with easy access to Genentech information for stories in development. It also houses our recent and archived press releases.

News Event

Arbitration Panel Decision Received in Decision-Making Disagreement Between Genentech and Biogen Idec

Genentech and our collaborator Biogen Idec disagreed over decision-making rights for certain of the next-generation anti-CD20 products under our 2003 collaboration agreement, and the disagreement was submitted to an arbitration panel, which issued a ruling in June 2009.

Read more about the arbitration panel decision.

Follow Genentech on Twitter

Twitter LogoFollow Genentech on Twitter to receive the latest news and updates about
the company.



Recent Press Releases

Jul 2, 2009
Phase III Study Showed Lucentis Improved Vision in Patients with Branch Retinal Vein Occlusion

May 30, 2009
Genentech Announces Full Results from First Phase III Study of Avastin in Early-Stage Colon Cancer

May 30, 2009
Phase III Study Showed Patients Lived Longer Without Advanced Lung Cancer Progressing When Tarceva Was Added to Avastin as First-Line Maintenance Therapy

May 29, 2009
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival in Advanced Breast Cancer


MEDIA INQUIRIES

If you are a member of the media, please call our Corporate Relations department.

Corporate Relations: (650) 467-6800

SIGN UP FOR GENENTECH NEWS

Receive e-mail alert messages whenever a new press release is posted to this site.

NEWSROOM FEEDBACK

Please take a moment to fill out our .